Since most Hsp90 inhibitors activate HSF-1 that induces the transcription of cytoprotective and tumor-promoting stress proteins such as Hsp70 and Hsp27, a combined approach consisting of HSF-1 knockdown (k.d.)and Hsp90 inhibition was investigated. The gene discussed is HSF1; the disease is neoplasm.